Evidence map›Paper›PMID 29310624›Full record

ArticleBMC psychiatry2018

ADHD medication in offspring of immigrants - does the income level of the country of parental origin matter?

Arzu Arat, Viveca Östberg, Bo Burström, Anders Hjern

Open access · goldAbstract readEvaluation Study
In one paragraph

Article in BMC psychiatry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Developmental disorders among Norwegian-born children with immigrant parents.Child and adolescent psychiatry and mental health · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Arzu AratDepartment of Medicine, Karolinska Institute, 171 76, Stockholm, Sweden. arzu.arat@chess.su.se.ORCID 0000-0002-1146-7269
Viveca ÖstbergCentre for Health Equity Studies (CHESS), Stockholm University/Karolinska Institute, 106 91, Stockholm, Sweden.
Bo BurströmDepartment of Public Health Sciences, Karolinska Institute, 171 77, Stockholm, Sweden.
Anders HjernDepartment of Medicine, Karolinska Institute, 171 76, Stockholm, Sweden.
Karolinska Institutet · SEStockholm University · SE

Funding

Horizon 2020 Framework Programme 634201
6 · The paper itself

Abstract

backgroundChild psychiatric treatment facilities vary greatly worldwide and are virtually non-existent in many low-income countries. One of the most common psychiatric disorders in childhood is ADHD, with an estimated prevalence of 3-5% in Sweden. Previous studies have shown a similar prevalence of ADHD in minority and majority children in Sweden and the UK. However, clinical studies demonstrated that children from immigrant families living in Sweden received less psychiatric care than those of native-born parents. We tested the hypothesis that the consumption of child psychiatric care in immigrant families would be determined by the availability of such treatment in the parents' country of origin. Patterns of medication for attention-deficit hyperactivity disorder (ADHD) were studied as a proxy for child psychiatric care.

methodsThis was a register study of dispensed stimulant medication during 2013-2014 in Swedish national birth cohorts from 1995-2009. The study population, consisting of nearly 1.4 million children, was divided by national income of the parental country of origin and whether the parents were native Swedes, European immigrants, non-European immigrants or a mixture. Logistic regression was used to calculate the odds ratios of having been dispensed at least one ADHD drug during 2013, with adjustments for gender, family status indicating whether the child is living with both parents, household income and area of residence.

resultsHaving parents born in low-income (OR [95% confidence interval] 0.27 [0.24-0.29]) or middle-income (European: OR 0.23 [0.20-0.26], non-European: OR 0.39 [0.34-0.41]) countries was associated with lower ADHD treatment levels than having parents born in high-income countries (European: OR 0.60 [0.54-0.66], non-European: OR 0.68 [0.59-0.79]), when compared to children of parents born in Sweden. In families with a background in low or middle income countries, there was no significant association between household income and ADHD medication, while in children with Swedish and mixed backgrounds high level of disposable income was associated with lower levels of ADHD medication.

conclusionThe use of child psychiatric care by immigrant families in Sweden was largely associated with the income level of the country of origin.

Indexed as

ParentsAdolescentAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsChildDeveloping CountriesEmigrants and ImmigrantsFemaleHumansIncomeLogistic ModelsMaleOdds RatioRegistriesSocial ClassSwedenCentral Nervous System StimulantsAttention-deficit hyperactivity disorderChild mental health servicesHealth inequalitiesImmigrant familiesIncome levels

Identifiers

PMID29310624
PMCPMC5759312
OpenAlexW2784229096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.